Wall Street Analysts Believe CorMedix (CRMD) Could Rally 65.96%: Here's is How to Trade

CorMedix’s consensus price target implies ~66% upside, though the article notes that price targets have limited predictive value. The near-term positive catalyst cited is an upward revision trend in earnings estimates, which could support the stock’s upside in the coming period.

Analysis

CorMedix’s consensus price target implies ~66% upside, though the article notes that price targets have limited predictive value. The near-term positive catalyst cited is an upward revision trend in earnings estimates, which could support the stock’s upside in the coming period.